| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/15/2006 | CN1241638C IFNAR2/I FN complex |
| 02/14/2006 | US6998383 Inhibitors of receptor activator of NF-κB and uses thereof |
| 02/14/2006 | CA2384170C Cgmp-visualizing probe and method of detecting and quantifying cgmp by using the same |
| 02/09/2006 | WO2006013106A2 Vaccine for prevention and treatment of hiv-infection |
| 02/09/2006 | WO2002097110A3 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060030000 Growth factor binding constructs materials and methods |
| 02/09/2006 | US20060029602 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 02/09/2006 | US20060029595 Methods of using human receptor protein 4-1BB |
| 02/09/2006 | US20060029593 Immunoglobulins having complementarity determining regions, heavy and light chain variable regions from humans that specifically bind to an antigen with affinity, used for in vivo therapy and diagnosis |
| 02/09/2006 | DE102004031258A1 Proteinhybride mit polyhydroxyaromatischen Aminosäure-Epitopen Protein hybrids with polyhydroxy aromatic amino acid epitopes |
| 02/09/2006 | CA2567795A1 Methods of treating type i diabetes by blocking vegf-mediated activity |
| 02/08/2006 | EP1624304A1 Probe for detecting and quantifying lipid second messenger and method of detecting and quantifying lipid second messenger using the same |
| 02/08/2006 | EP1623990A2 Compositions and methods for the treatment of tumours |
| 02/08/2006 | EP1623989A1 Compositions and methods for the diagnosis of tumours |
| 02/08/2006 | EP1623036A2 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2006 | EP1622563A2 Improved heat shock protein-based vaccines and immunotherapies |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1114062B1 Modified e.coli enterotoxin ii signal peptide and a microorganism expressing a fusion protein of said peptide and a heterologous protein |
| 02/08/2006 | CN1240840C Method of revealing target protein on cell surface using bactospein S layer protein as carrier and application thereof |
| 02/08/2006 | CN1240721C Conjugate of lidamycin, monoclonal antibody and its Fab'segment and its application in targeting treatment of colon cancer and other tumors |
| 02/08/2006 | CN1240717C Low-toxicity human interferon-alpha analog |
| 02/07/2006 | US6995241 Acute Neuronal Induced Calcium-Binding Protein (ANIC-BP-1B) polypeptides and polynucleotides; diagnostic assays; neuroprotectants; agonists; antagonists; stroke , Parkinson's disease, Alzheimer disease, multiple sclerosis and spinal cord injuries |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 02/06/2006 | CA2511314A1 Novel recombinant t4 phage particle and uses thereof |
| 02/02/2006 | WO2006012415A2 Rage protein derivatives |
| 02/02/2006 | US20060025576 Multivalent antibodies and uses therefor |
| 02/02/2006 | US20060025573 Reducing the immunogenicity of fusion proteins |
| 02/02/2006 | US20060025572 Mammalian cell surface antigens; related reagents |
| 02/02/2006 | US20060025362 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 02/02/2006 | US20060024820 Chromosome-based platforms |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024766 Bifunctional molecules |
| 02/02/2006 | US20060024759 Complex of a chaperone with beta-amyloid and methods employing this complex |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | CA2574802A1 Specific inhibition of autoimmunity and diseases associated with autoantigens |
| 02/01/2006 | EP1621555A1 Immunogen, composition for immunological use, and method of producing antibody using the same |
| 02/01/2006 | EP1621554A1 Immunoglobulins devoid of light chains |
| 02/01/2006 | EP1621206A1 Chimeric cytokines and uses thereof |
| 02/01/2006 | EP1200479B1 Multiple cytokine-antibody complexes |
| 02/01/2006 | EP1100928B1 Bifunctional enzymes for biopolymer production |
| 02/01/2006 | CN1727362A Preparation and application of vaccine for curing tumor in positive carcino-embryonic antigen |
| 02/01/2006 | CN1239701C Humanised antibodies to epidermal growth factor receptor |
| 01/31/2006 | US6992174 Reducing the immunogenicity of fusion proteins |
| 01/31/2006 | CA2390104C Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 01/26/2006 | WO2005108562A3 Synthetic fluorouridine-activating enzyme for cancer therapy |
| 01/26/2006 | WO2004013160A3 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 01/26/2006 | US20060020114 Apo-2DcR |
| 01/26/2006 | US20060019240 Posh nucleic acids, polypeptides and related methods |
| 01/26/2006 | US20060018903 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 01/26/2006 | US20060018895 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 01/25/2006 | EP1619250A1 WSX receptor and ligands |
| 01/25/2006 | EP1617870A2 Single chain antigen-binding polypeptides for polymer conjugation |
| 01/25/2006 | CN1726283A Production of multimeric fusion proteins using a C4BP scaffold |
| 01/25/2006 | CN1726228A Monitor protein for measuring processing of protein |
| 01/25/2006 | CN1726227A Humanized antibody (H14.18) of the mouse 14.18 antibody binding to GD2 and its fusion with 1L-2 |
| 01/25/2006 | CN1724570A Anthrax toxin acceptor ATR-Fc fusion protein |
| 01/25/2006 | CN1238382C Molt-inhibiting hormone-1 protein of mitten crab |
| 01/25/2006 | CN1238381C Anti-cancer surface antigen of p185 mono-antigen mosaic antibody and its preparation |
| 01/24/2006 | US6989365 Methods of treatment with erythropoietin and albumin fusion protein |
| 01/24/2006 | US6989146 Stress proteins and peptides and methods of use thereof |
| 01/21/2006 | CA2512515A1 Super-antigen fusion proteins and the use thereof |
| 01/19/2006 | WO2006005588A1 Polypeptide species useful for the treatment of neurological disorders |
| 01/19/2006 | WO2004094620A3 Truncated baff receptors |
| 01/19/2006 | US20060014245 Immunotoxins containing a cytotoxic RNAse fused to the N-terminus of one antibody variable domain prepared and retain the ability to specifically bind antigen; cancer |
| 01/19/2006 | US20060014139 Which comprises three N-helices and at least two, but not three, of the three C-helices of the trimer-of-hairpin structure of HIV gp41; inhibits infection of cells; drug screening; gene therapy |
| 01/19/2006 | US20060013800 Stable immunogenic product comprising antigenic heterocomplexes |
| 01/19/2006 | DE10247755B4 Selektive, lokale Aktivierung von Mitgliedern der TNF-Rezeptorfamilie durch systemisch inaktive nicht-Antikörper-TNF-Liganden-Fusionsproteine Selective, local activation of members of the TNF receptor family by systemically inactive non-antibody-TNF-ligand fusion proteins |
| 01/19/2006 | CA2553436A1 Peptides selectively lethal to malignant and transformed mammalian cells |
| 01/18/2006 | EP1616961A1 Vectors and methods for gene transfer to cells |
| 01/18/2006 | EP1616958A2 Notch-ligands for use in immunotherapy |
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616875A1 GD3-mimetic peptides |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1278851B1 Humanised antibodies to the epidermal growth factor receptor |
| 01/18/2006 | CN1723284A Regulatory zinc finger proteins |
| 01/18/2006 | CN1723282A Protein complex, process for producing the same and use thereof |
| 01/18/2006 | CN1723220A A pharmaceutical composition comprising an immunoglobulin FC region as a carrier |
| 01/18/2006 | CN1723219A Protein complex using immunoglobulin fragment andmethod for the preparation thereof |
| 01/18/2006 | CN1723041A Stable immunogenic product comprising antigenic heterocomplexes |
| 01/18/2006 | CN1723032A Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/18/2006 | CN1721446A Fusion protein and method for preparing same |
| 01/18/2006 | CN1721444A Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 01/18/2006 | CN1721443A Human receptor proteins, related reagents and methods |
| 01/18/2006 | CN1721430A Bacteriophage containing short-peptide specifically combined with avian infectious bronchitis virus and use thereof |
| 01/17/2006 | US6987172 Multifunctional single chain glycoprotein hormones comprising three or more β subunits |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/17/2006 | US6987006 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 01/17/2006 | CA2374882C Molecular characterisation of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis |
| 01/12/2006 | WO2006004173A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 01/12/2006 | US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/12/2006 | US20060008474 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 01/12/2006 | US20060008460 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease |
| 01/12/2006 | CA2572129A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 01/12/2006 | CA2571957A1 Methods and compositions using cd3 agonists |
| 01/11/2006 | EP1614695A1 Polypeptide |
| 01/11/2006 | EP1613660A2 Compositions and methods relating to stop-1 |